Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NQ:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Factors of Influence in 2018, Key Indicators and Opportunity within MannKind, Healthcare Services Group, Cadence, Superior Energy Services, National Presto Industries, and New Media Investment Group —
June 29, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MannKind Corporation...
From
GlobeNewswire News Releases
MannKind to Host Institutional Investor and Analyst Meeting
June 20, 2018
MannKind Corporation (Nasdaq:MNKD) today announced that it will host an invitation-only luncheon at Lotte New York Palace on Wednesday, June 27, 2018 for institutional investors and analysts, also...
From
GlobeNewswire News Releases
MannKind Establishes Market Price Stock Purchase Plan
June 05, 2018
MannKind Corporation (NASDAQ:MNKD) has established a stock purchase plan that provides MannKind’s directors and executive officers with a way to purchase shares of common stock directly from the...
From
GlobeNewswire News Releases
MannKind Corporation Reports 2018 First Quarter Financial Results
May 09, 2018
Conference Call to Begin Today at 5:00 PM ET
From
GlobeNewswire News Releases
MannKind and Cipla Enter an Exclusive Marketing and Distribution Agreement for Afrezza® in India
May 09, 2018
MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial...
From
GlobeNewswire News Releases
FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary
April 25, 2018
MannKind Corporation (Nasdaq:MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...
From
GlobeNewswire News Releases
MannKind Announces Completion of Previously Announced $28.0 Million Registered Direct Offering
April 09, 2018
MannKind Corporation (Nasdaq:MNKD) today announced the completion of its previously announced registered direct offering of 14,000,000 shares of common stock and warrants to purchase up to an aggregate...
From
GlobeNewswire News Releases
MannKind Opens Enrollment of Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension
March 01, 2018
MannKind Corporation (Nasdaq:MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,...
From
GlobeNewswire News Releases
Gene Therapy Holds Out Hope for Diabetics
February 28, 2018
From
PR Newswire
MannKind Corporation Reports 2017 Fourth Quarter and Full Year Financial Results
February 27, 2018
Conference Call to Begin Today at 5:00 PM ET
From
GlobeNewswire News Releases
David Kendall Joins MannKind as Chief Medical Officer
February 06, 2018
MannKind Corporation (NASDAQ:MNKD) today announced that David M. Kendall, MD, will join the company as Chief Medical Officer and assume full responsibility for leading MannKind’s scientific research,...
From
GlobeNewswire News Releases
MannKind Corporation (NASDAQ:MNKD) Shareholder Notice: Lawsuit Against H.C. Wainwright & Co., LLC
November 27, 2017
San Diego, CA -- (SBWIRE) -- 11/27/2017 -- An investor, who purchased shares of MannKind Corporation (NASDAQ:MNKD), filed a lawsuit against H.C. Wainwright & Co., LLC and financial analyst, Oren Livnat...
From
SBWire - Latest Press Releases
MannKind Corporation Reports 2017 Third Quarter Financial Results
November 07, 2017
Conference Call to Begin Today at 5:00 PM ET
From
GlobeNewswire News Releases
Stock reports released for BlackRock Incorporated, Delta Airlines, MannKind, Snap Inc. and Tesla Motors?
October 11, 2017
InvestorsObserver issues critical PriceWatch Alerts for BLK, DAL, MNKD, SNAP, and TSLA.
From
PR Newswire
3 Tech Stocks Investors Are Watching
October 05, 2017
From
ACCESSWIRE
3 Biotech Stocks That Are Trending Pre-Market On Monday
October 02, 2017
From
ACCESSWIRE
A Small Cap Stock Making Big Cap Waves
September 07, 2017
From
ACCESSWIRE
3 Stocks Capitalizing Off Positive Market Momentum On Wednesday
August 30, 2017
From
ACCESSWIRE
MannKind Corporation Reports 2017 Second Quarter Financial Results
August 07, 2017
Conference Call to Begin Today at 5:00 PM ET
From
GlobeNewswire News Releases
MannKind and One Drop Partner to Launch the A-ONE Clinical Trial
August 07, 2017
Study will utilize Afrezza® inhaled insulin and the One Drop digital diabetes care platform
From
GlobeNewswire News Releases
MannKind Renegotiates Near-Term Maturities with Deerfield
June 29, 2017
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) and affiliates of Deerfield Management Company L.P. (“Deerfield”) have entered into an exchange and third amendment to their facility agreement (the...
From
GlobeNewswire News Releases
MannKind and Biomm Enter Into Distribution Agreement for Afrezza in Brazil
May 31, 2017
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that they have entered into a supply and distribution agreement for the commercialization of Afrezza® (insulin...
From
GlobeNewswire News Releases
MannKind Corporation Reports 2017 First Quarter Financial Results
May 10, 2017
Conference Call to Begin Today at 5:00 PM ET
From
GlobeNewswire News Releases
MannKind Corporation Reports 2016 Fourth Quarter and Full Year Financial Results
March 16, 2017
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2016. Key results include:
From
GlobeNewswire News Releases
MannKind Receives $16.7 Million From Sale of Valencia Property
February 21, 2017
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today confirmed that it received $16.7 million on February 17, 2017, upon closing the sale of real estate owned by the Company in Valencia, California,...
From
GlobeNewswire News Releases
Biotech Stocks Under Scanner -- Mast Therapeutics, MannKind, Celgene, and Opko Health
February 02, 2017
From
PR Newswire
MannKind Announces Launch of New Titration Pack and Field Force Expansion to Accelerate Afrezza® Growth
February 01, 2017
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), a fully integrated biopharmaceutical company focusing on the discovery and development of therapeutic products for patients with diseases such as...
From
GlobeNewswire News Releases
MannKind Corporation to Hold Investor Conference Call on February 1, 2017
January 27, 2017
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will host a conference call to discuss Company developments at 5:00 PM (Eastern Time) on February 1, 2017.
From
GlobeNewswire News Releases
FinancialBuzz.com: Advances in Biotechnology Sector
January 09, 2017
From
PR Newswire
MannKind Receives $30.6 Million From Sanofi
January 09, 2017
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today confirmed that it received $30.6 million from Sanofi on January 6, 2017, representing the balance of the accelerated insulin “put” option previously...
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.